Amgen had three patents in internet of things during Q2 2024. Amgen Inc has developed a system for out-patient treatment with immunotherapy that activates T cells to fight cancer. This system includes an infusion pump, a wearable device for acquiring sensor data related to cytokine detection, and remote communication with healthcare providers. Additionally, a computer-readable medium with instructions for monitoring patient health based on sensor data from immunotherapy treatment is provided. GlobalData’s report on Amgen gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Amgen had no grants in internet of things as a theme in Q2 2024.
Recent Patents
Application: Systems for out-patient treatment of a patient, and related methods (Patent ID: US20240197989A1)
The patent filed by Amgen Inc. describes a system for out-patient treatment with immunotherapy that activates T cells to fight cancer. The system includes an infusion pump, a wearable device with sensors to detect patient vital signs, and wireless communication with a healthcare provider based on the acquired sensor data. The wearable device continuously measures indicators such as heart rate, temperature, respiratory rate, and oxygen saturation, and can send real-time or periodic messages to the healthcare provider, as well as generate warnings based on the sensor data.
The system is designed to monitor patients receiving immunotherapy that may trigger an immune inflammatory response, leading to increased risk factors of cytokine release syndrome or neurotoxicity. The wearable device can detect vital signs indicative of these conditions, such as heart rate, temperature, respiratory rate, oxygen saturation, and blood pressure. The system also includes features like an axillary temperature sensor, a blood pressure cuff, and wireless communication modules for seamless data transmission between the wearable device and healthcare provider devices, enabling timely intervention and support for patients undergoing out-patient immunotherapy treatment.
To know more about GlobalData’s detailed insights on Amgen, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
